These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

181 related articles for article (PubMed ID: 8971088)

  • 21. Pyridoxamine inhibits early renal disease and dyslipidemia in the streptozotocin-diabetic rat.
    Degenhardt TP; Alderson NL; Arrington DD; Beattie RJ; Basgen JM; Steffes MW; Thorpe SR; Baynes JW
    Kidney Int; 2002 Mar; 61(3):939-50. PubMed ID: 11849448
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Effects of aminoguanidine and tolrestat on the development of ocular and renal structural changes in experimental diabetic rats.
    Azal O; Yönem A; Güler S; Cakir B; Baydar A; Corakçi A; Kutlu M
    Diabetes Obes Metab; 2002 Jan; 4(1):75-9. PubMed ID: 11874446
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The effects of aminoguanidine on renal changes in a baboon model of Type 1 diabetes.
    Birrell AM; Heffernan SJ; Kirwan P; McLennan S; Gillin AG; Yue DK
    J Diabetes Complications; 2002; 16(4):301-9. PubMed ID: 12126789
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Effects of aminoguanidine in preventing experimental diabetic nephropathy are related to the duration of treatment.
    Soulis T; Cooper ME; Vranes D; Bucala R; Jerums G
    Kidney Int; 1996 Aug; 50(2):627-34. PubMed ID: 8840295
    [TBL] [Abstract][Full Text] [Related]  

  • 25. C-peptide prevents glomerular hypertrophy and mesangial matrix expansion in diabetic rats.
    Samnegård B; Jacobson SH; Jaremko G; Johansson BL; Ekberg K; Isaksson B; Eriksson L; Wahren J; Sjöquist M
    Nephrol Dial Transplant; 2005 Mar; 20(3):532-8. PubMed ID: 15665028
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Effect of treating streptozotocin-induced diabetic rats with sorbinil, myo-inositol or aminoguanidine on endoneurial blood flow, motor nerve conduction velocity and vascular function of epineurial arterioles of the sciatic nerve.
    Coppey LJ; Gellett JS; Davidson EP; Dunlap JA; Yorek MA
    Int J Exp Diabetes Res; 2002; 3(1):21-36. PubMed ID: 11900277
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Advanced glycosylation end products, protein kinase C and renal alterations in diabetic rats.
    Rong J; Qiu H; Wang S
    Chin Med J (Engl); 2000 Dec; 113(12):1087-91. PubMed ID: 11776142
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The effect of an aldose reductase inhibitor (Epalrestat) on diabetic nephropathy in rats.
    Itagaki I; Shimizu K; Kamanaka Y; Ebata K; Kikkawa R; Haneda M; Shigeta Y
    Diabetes Res Clin Pract; 1994 Oct; 25(3):147-54. PubMed ID: 7851268
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Prevention of diabetic nephropathy in db/db mice with glycated albumin antagonists. A novel treatment strategy.
    Cohen MP; Sharma K; Jin Y; Hud E; Wu VY; Tomaszewski J; Ziyadeh FN
    J Clin Invest; 1995 May; 95(5):2338-45. PubMed ID: 7738197
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Advanced glycation end products and their receptors co-localise in rat organs susceptible to diabetic microvascular injury.
    Soulis T; Thallas V; Youssef S; Gilbert RE; McWilliam BG; Murray-McIntosh RP; Cooper ME
    Diabetologia; 1997 Jun; 40(6):619-28. PubMed ID: 9222639
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Modulation of hemodynamic and vascular filtration changes in diabetic rats by dietary myo-inositol.
    Pugliese G; Tilton RG; Speedy A; Santarelli E; Eades DM; Province MA; Kilo C; Sherman WR; Williamson JR
    Diabetes; 1990 Mar; 39(3):312-22. PubMed ID: 2307293
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Non-enzymatic glycation and altered renal structure and function in the diabetic rat.
    Copeland KR; Yatscoff RW; Thliveris JA; Mehta A; Penner B
    Kidney Int; 1987 Nov; 32(5):664-70. PubMed ID: 3430955
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Effects of islet isografts on hemodynamic and vascular filtration changes in diabetic rats.
    Pugliese G; Tilton RG; Chang K; Speedy A; Province M; Eades DM; Lacy PE; Kilo C; Williamson JR
    Diabetes; 1990 Mar; 39(3):323-32. PubMed ID: 2106462
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Real-time observation of glomerular hemodynamic changes in diabetic rats: effects of insulin and ARB.
    Li B; Yao J; Kawamura K; Oyanagi-Tanaka Y; Hoshiyama M; Morioka T; Gejyo F; Uchiyama M; Oite T
    Kidney Int; 2004 Nov; 66(5):1939-48. PubMed ID: 15496165
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Reduction of glomerular hyperfiltration by dopamine D(2)-like receptor blockade in experimental diabetes mellitus.
    Luippold G; Beilharz M; Mühlbauer B
    Nephrol Dial Transplant; 2001 Jul; 16(7):1350-6. PubMed ID: 11427624
    [TBL] [Abstract][Full Text] [Related]  

  • 36. LR-90 a new advanced glycation endproduct inhibitor prevents progression of diabetic nephropathy in streptozotocin-diabetic rats.
    Figarola JL; Scott S; Loera S; Tessler C; Chu P; Weiss L; Hardy J; Rahbar S
    Diabetologia; 2003 Aug; 46(8):1140-52. PubMed ID: 12845431
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Curcumin, Alone or in Combination with Aminoguanidine, Increases Antioxidant Defenses and Glycation Product Detoxification in Streptozotocin-Diabetic Rats: A Therapeutic Strategy to Mitigate Glycoxidative Stress.
    Lima TFO; Costa MC; Figueiredo ID; Inácio MD; Rodrigues MR; Assis RP; Baviera AM; Brunetti IL
    Oxid Med Cell Longev; 2020; 2020():1036360. PubMed ID: 32566072
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Aminoguanidine treatment reduces the increase in collagen stability of rats with experimental diabetes mellitus.
    Oxlund H; Andreassen TT
    Diabetologia; 1992 Jan; 35(1):19-25. PubMed ID: 1541376
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Effects of very mild versus overt diabetes on vascular haemodynamics and barrier function in rats.
    Pugliese G; Tilton RG; Speedy A; Chang K; Santarelli E; Province MA; Eades D; Sherman WR; Williamson JR
    Diabetologia; 1989 Dec; 32(12):845-57. PubMed ID: 2533117
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Response of capillary cell death to aminoguanidine predicts the development of retinopathy: comparison of diabetes and galactosemia.
    Kern TS; Tang J; Mizutani M; Kowluru RA; Nagaraj RH; Romeo G; Podesta F; Lorenzi M
    Invest Ophthalmol Vis Sci; 2000 Nov; 41(12):3972-8. PubMed ID: 11053301
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.